Seelos Therapeutics
SEEL
#10722
Rank
C$0.29 M
Marketcap
C$0.52
Share price
-31.49%
Change (1 day)
-98.13%
Change (1 year)

Earnings for Seelos Therapeutics (SEEL)

Earnings in 2024 (TTM): C$5.91 Million

According to Seelos Therapeutics 's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -C$52.65 Million, an increase over its 2022 earnings that were of -C$0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Seelos Therapeutics from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) C$5.91 M-111.24%
2023 -C$52.65 Million-48.58%
2022 -C$0.11 Billion14.07%
2021 -C$89.74 Million240.34%
2020 -C$26.37 Million-62.76%
2019 -C$70.81 Million587.73%
2018 -C$10.3 Million-36.54%
2017 -C$16.23 Million74.83%
2016 -C$9.28 Million-63.26%
2015 -C$25.26 Million-18.06%
2014 -C$30.83 Million46.19%
2013 -C$21.09 Million-31.67%
2012 -C$30.86 Million
2010 -C$28.91 Million448.63%
2009 -C$5.27 Million-25.83%
2008 -C$7.11 Million-45.65%
2007 -C$13.07 Million2.82%
2006 -C$12.72 Million-41.86%
2005 -C$21.87 Million-9.27%
2004 -C$24.1 Million114.92%
2003 -C$11.22 Million-70.78%
2002 -C$38.38 Million60.2%
2001 -C$23.96 Million70.3%
2000 -C$14.07 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-C$0.21 Billion-3,626.04%๐Ÿ‡บ๐Ÿ‡ธ USA